Guided Therapeutics (GTHP) Long-Term Investments (2025 - 2026)
Guided Therapeutics (GTHP) posted Long-Term Investments of $472502.0 for Q4 2025.
Guided Therapeutics (GTHP) Long-Term Investments (2025 - 2026) Analysis & Trends
Guided Therapeutics has reported Long-Term Investments for 1 years, with the latest figure at $472502.0 in Q4 2025.
- Quarterly Long-Term Investments changed N/A year-over-year to $472502.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $472502.0 (changed N/A YoY) and the FY2025 annual result came in at $472502.0, changed N/A from the prior year.
- Long-Term Investments steadied at $472502.0 in Q4 2025 per GTHP's latest filing.
- Over five years, Long-Term Investments peaked at $472502.0 in Q4 2025 and troughed at $472502.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 557,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 557,000.00 |
| Dec 31, 2025 | 472,502.00 |